Showing results (1-10 of 2,248) with videos related to
Sort By:
Pageof 225
Journal of Inherited Metabolic Disease|January 1, 1992
Bone marrow transplantation for Sanfilippo disease type BA Vellodi, E Young, M New, et al.Journal of Clinical Pharmacology|November 1, 1987
Hemiplegia and focal convulsions as a manifestation of cyclosporine A toxicityA Vellodi, R Jayatunga, K Hugh-JonesClinical and Experimental Immunology|June 1, 1992
Class- and subclass-specific pneumococcal antibody levels and response to immunization after bone marrow transplantationJ E Lortan, A Vellodi, E S Jurges, et al.British Medical Journal (Clinical Research Ed.)|November 28, 1987
Treatment of Niemann-Pick disease type B by allogeneic bone marrow transplantationA Vellodi, J R Hobbs, N M O'Donnell, et al.Biochemical Society Transactions|May 18, 2000
The molecular basis of lysosomal storage diseases and their treatmentB Winchester, A Vellodi, E YoungJournal of Inherited Metabolic Disease|August 1, 1997
Plasma chitotriosidase activity in Gaucher disease patients who have been treated either by bone marrow transplantation or by enzyme replacement therapy with algluceraseE Young, C Chatterton, A Vellodi, et al.BMJ (Clinical Research Ed.)|October 1, 1994
Cognitive function and behavioural status in paediatric heart and heart-lung transplant recipients: the Harefield experienceJ Wray, C Pot-Mees, H Zeitlin, et al.Journal of Inherited Metabolic Disease|July 10, 1999
Long-term follow-up following bone marrow transplantation for Hunter diseaseA Vellodi, E Young, A Cooper, et al.Acta Paediatrica (Oslo, Norway : 1992). Supplement|May 18, 2005
Is globotriaosylceramide a useful biomarker in Fabry disease?E Young, K Mills, P Morris, et al.Journal of Inherited Metabolic Disease|February 11, 2005
Measurement of urinary CDH and CTH by tandem mass spectrometry in patients hemizygous and heterozygous for Fabry diseaseK Mills, P Morris, P Lee, et al.Pageof 225